Ideal for use by Pharmacists, Chemists, Nurses and Doctors within Hospitals, Nursing Homes, Pharmacies and Hospices and the ideal reference tool for all Care and support staff. See also: If you have re-registered as an NHS user, thank you, your access to BNF content through MedicinesComplete is also confirmed. Please report metadata errors at the source library. If there are multiple source libraries, know that we pull metadata from top to bottom, so the first one might be sufficient. MD5 of a better version of this file (if applicable). Fill this in if there is another file that closely matches this file (same edition, same file extension if you can find one), which people should use instead of this file. If you know of a better version of this file outside of Anna’s Archive, then please upload it.

The latest new drugs and significant changes to medicines information on MedicinesComplete - monthly. Ibrutinib (Imbruvica®): new risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac eventsThe results of this research have enabled us to critically review the information that should be included within specialist drug monographs. “Specialist drug” monographs will contain less detail than a regular monograph within BNF Publications, in a consistent format. A “specialist” monograph will continue to include information to support patient safety and non-specialist patient care (such as important safety information, interactions, side-effects, and contra-indications), but it will not contain information which is within the remit of specialist care (such as doses, and directions for administration). The current level of additional prescribing information has been retained for drug monographs that have a mix of specialist and non-specialist uses (such as methotrexate that is used for both malignancy and rheumatological conditions). The search functionality through MedicinesComplete makes it easy for health professionals to find drugs, view monographs, and browse related information to support confident decision making. Updated monographs or dose changes: Erythromycin, Colecalciferol and ergocalciferol, Metolazone (Xaqua)

As noted in the British National Formulary (BNF) the recommended dosage for children under 12 is...(Joint Formulary Committee, 2021)." Livtencity® [maribavir] for cytomegalovirus disease in recipients of haematopoietic stem cell transplant or solid organ transplant Read the BNF newsletter for the latest guidance and content updates to the BNF and BNF for Children. Sign up to the BNF monthly newsletter.BNF 78 New drug monographs: Ertugliflozin (Steglatro), Insulin glargine with lixisenatide (Suliqua), Stiripentol (Diacomit) Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017) The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care. This is amazing! Who knew we had access to all of these books? Very pleased with this unexpected benefit for members.” Oral valganciclovir 900 mg twice daily is equivalent to intravenous ganciclovir 5 mg/kg twice daily.

At Medicalstudyzone.com, we take user experience very seriously and thus always strive to improve. We hope that you people find our blog beneficial! If you’re a UK-based individual undertaking work or training for the NHS, you can register for access to BNF content on MedicinesComplete. As a registered NHS user, you’ll get single user access to BNF and BNF for Children content on MedicinesComplete for 365 days. Vaccine monographs in the BNF and BNF for Children have been updated to more clearly identify whether a vaccine is live or not.The BNF is jointly published by the Royal Pharmaceutical Society and BMJ. BNF is published in print twice a year and interim updates are issued and published monthly in the digital versions. The following summary provides a brief description of some recent key changes that have been made to BNF content. The British National Formulary (BNF) is a book that is published twice a year in March and September. Compiled with the advice of clinical experts, its an essential reference providing up to date guidance on the prescribing, dispensing and administration of medicines. British National Formulary (BNF) Product Details: For each vaccine monograph, the Drug action section includes a short summary of the vaccine type. Detailed information on the vaccine’s mechanism of action can be found in the corresponding Treatment summaries. The classifications, which are used to group similar vaccines, have also been updated. The new edition (BNF 84) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.